V. М. Perelmuter

1.9k citations
108 papers · 1.3k indexed · h-index 20

V. М. Perelmuter

92 papers receiving 1.2k citations

Peers

V. М. Perelmuter
Comparison fields: 5 of 105
  • Cancer Research 390
  • Oncology 600
  • Cell Biology 196
  • Immunology and Allergy 63
  • Immunology 160
Replace М. V. Zavyalova with:
М. V. Zavyalova Russia
Franziska van Zijl Austria
Kideok Jin United States
Douglas W. McMillin United States
Alexei V. Salnikov Germany
Bingbing Dai United States
Yubin Mao China
Isabel Chu United States
Dong Soon Choi United States
V. М. Perelmuter relative to М. V. Zavyalova Russia М. V. Zavyalova's profile →
Citations per field
00.5×1.5×
М. V. Zavyalova · 1×
Citations per year

Countries citing papers authored by V. М. Perelmuter

Since Specialization
Citations

This map shows the geographic impact of V. М. Perelmuter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. М. Perelmuter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. М. Perelmuter more than expected).

Fields of papers citing papers by V. М. Perelmuter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. М. Perelmuter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. М. Perelmuter. The network helps show where V. М. Perelmuter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside V. М. Perelmuter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with V. М. Perelmuter Line = papers co-authored together V. М. Perelmuter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20243
3 20241
4 20236
5 20230
6 20231
7 20230
8 202210
9 20220
10 20201
11 201961
12 201917
13 20181
14 20181
15 20183
16 201718
17 201710
18
CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF BILATERAL BREAST CANCER
20160
19 201365
20 20030

About V. М. Perelmuter

V. М. Perelmuter is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 108 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (39 papers), Cancer Immunotherapy and Biomarkers (17 papers), Cancer Genomics and Diagnostics (11 papers), Metastasis and carcinoma case studies (10 papers), Immunotherapy and Immune Responses (9 papers), Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Immune cells in cancer (7 papers). The work is most often cited by research in Cancer Research (390 citations), Oncology (600 citations) and Cell Biology (196 citations). V. М. Perelmuter has collaborated with scholars based in Russia, United States and United Kingdom. Frequent co-authors include Evgeny V. Denisov, М. V. Zavyalova, С. В. Вторушин, N. V. Krakhmal, Н. В. Чердынцева, Л. А. Таширева, O. E. Savelieva, Tatiana S. Gerashchenko, Н. В. Литвяков and Е. В. Кайгородова. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026